Neuberger Berman Group »

Cogent Biosciences shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 384k 38.70
2026-03-31 $233k 6.1k 38.49

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
State Street Corporation
Fairmount Funds Management
Deerfield Management Company
TCG Crossover Management
Geode Capital Management
Wellington Management Company
Kynam Capital Management
Lord, Abbett & Co
Polar Capital Holdings

View all funds holding Cogent Biosciences